Cargando…

Dimethylguanidino Valerate: A Lifestyle‐Related Metabolite Associated With Future Coronary Artery Disease and Cardiovascular Mortality

BACKGROUND: Identification of lifestyle modifiable metabolic pathways related to cardiometabolic disease risk is essential for improvement of primary prevention in susceptible individuals. It was recently shown that plasma dimethylguanidino valerate (DMGV) levels are associated with incident type 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Ottosson, Filip, Ericson, Ulrika, Almgren, Peter, Smith, Einar, Brunkwall, Louise, Hellstrand, Sophie, Nilsson, Peter M., Orho‐Melander, Marju, Fernandez, Céline, Melander, Olle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6806048/
https://www.ncbi.nlm.nih.gov/pubmed/31533499
http://dx.doi.org/10.1161/JAHA.119.012846
_version_ 1783461538121646080
author Ottosson, Filip
Ericson, Ulrika
Almgren, Peter
Smith, Einar
Brunkwall, Louise
Hellstrand, Sophie
Nilsson, Peter M.
Orho‐Melander, Marju
Fernandez, Céline
Melander, Olle
author_facet Ottosson, Filip
Ericson, Ulrika
Almgren, Peter
Smith, Einar
Brunkwall, Louise
Hellstrand, Sophie
Nilsson, Peter M.
Orho‐Melander, Marju
Fernandez, Céline
Melander, Olle
author_sort Ottosson, Filip
collection PubMed
description BACKGROUND: Identification of lifestyle modifiable metabolic pathways related to cardiometabolic disease risk is essential for improvement of primary prevention in susceptible individuals. It was recently shown that plasma dimethylguanidino valerate (DMGV) levels are associated with incident type 2 diabetes mellitus. Our aims were to investigate whether plasma DMGV is related to risk of future coronary artery disease and with cardiovascular mortality and to replicate the association with type 2 diabetes mellitus and pinpoint candidate lifestyle interventions susceptible to modulate DMGV levels. METHODS AND RESULTS: Plasma DMGV levels were measured using liquid chromatography‐mass spectrometry in a total of 5768 participants from the MDC (Malmö Diet and Cancer Study—Cardiovascular Cohort), MPP (Malmö Preventive Project), and MOS (Malmö Offspring Study). Dietary intake assessment was performed in the MOS. Baseline levels of DMGV associated with incident coronary artery disease in both the MDC (hazard ratio=1.29; CI=1.16–1.43; P<0.001) and MPP (odds ratio=1.25; CI=1.08–1.44; P=2.4e‐3). In the MDC, DMGV was associated with cardiovascular mortality and incident coronary artery disease, independently of traditional risk factors. Furthermore, the association between DMGV and incident type 2 diabetes mellitus was replicated in both the MDC (hazard ratio=1.83; CI=1.63–2.05; P<0.001) and MPP (odds ratio=1.65; CI=1.38–1.98; P<0.001). Intake of sugar‐sweetened beverages was associated with increased levels of DMGV, whereas intake of vegetables and level of physical activity was associated with lower DMGV. CONCLUSIONS: We discovered novel independent associations between plasma DMGV and incident coronary artery disease and cardiovascular mortality, while replicating the previously reported association with incident type 2 diabetes mellitus. Additionally, strong associations with sugar‐sweetened beverages, vegetable intake, and physical activity suggest the potential to modify DMGV levels using lifestyle interventions.
format Online
Article
Text
id pubmed-6806048
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-68060482019-10-28 Dimethylguanidino Valerate: A Lifestyle‐Related Metabolite Associated With Future Coronary Artery Disease and Cardiovascular Mortality Ottosson, Filip Ericson, Ulrika Almgren, Peter Smith, Einar Brunkwall, Louise Hellstrand, Sophie Nilsson, Peter M. Orho‐Melander, Marju Fernandez, Céline Melander, Olle J Am Heart Assoc Original Research BACKGROUND: Identification of lifestyle modifiable metabolic pathways related to cardiometabolic disease risk is essential for improvement of primary prevention in susceptible individuals. It was recently shown that plasma dimethylguanidino valerate (DMGV) levels are associated with incident type 2 diabetes mellitus. Our aims were to investigate whether plasma DMGV is related to risk of future coronary artery disease and with cardiovascular mortality and to replicate the association with type 2 diabetes mellitus and pinpoint candidate lifestyle interventions susceptible to modulate DMGV levels. METHODS AND RESULTS: Plasma DMGV levels were measured using liquid chromatography‐mass spectrometry in a total of 5768 participants from the MDC (Malmö Diet and Cancer Study—Cardiovascular Cohort), MPP (Malmö Preventive Project), and MOS (Malmö Offspring Study). Dietary intake assessment was performed in the MOS. Baseline levels of DMGV associated with incident coronary artery disease in both the MDC (hazard ratio=1.29; CI=1.16–1.43; P<0.001) and MPP (odds ratio=1.25; CI=1.08–1.44; P=2.4e‐3). In the MDC, DMGV was associated with cardiovascular mortality and incident coronary artery disease, independently of traditional risk factors. Furthermore, the association between DMGV and incident type 2 diabetes mellitus was replicated in both the MDC (hazard ratio=1.83; CI=1.63–2.05; P<0.001) and MPP (odds ratio=1.65; CI=1.38–1.98; P<0.001). Intake of sugar‐sweetened beverages was associated with increased levels of DMGV, whereas intake of vegetables and level of physical activity was associated with lower DMGV. CONCLUSIONS: We discovered novel independent associations between plasma DMGV and incident coronary artery disease and cardiovascular mortality, while replicating the previously reported association with incident type 2 diabetes mellitus. Additionally, strong associations with sugar‐sweetened beverages, vegetable intake, and physical activity suggest the potential to modify DMGV levels using lifestyle interventions. John Wiley and Sons Inc. 2019-09-19 /pmc/articles/PMC6806048/ /pubmed/31533499 http://dx.doi.org/10.1161/JAHA.119.012846 Text en © 2019 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Research
Ottosson, Filip
Ericson, Ulrika
Almgren, Peter
Smith, Einar
Brunkwall, Louise
Hellstrand, Sophie
Nilsson, Peter M.
Orho‐Melander, Marju
Fernandez, Céline
Melander, Olle
Dimethylguanidino Valerate: A Lifestyle‐Related Metabolite Associated With Future Coronary Artery Disease and Cardiovascular Mortality
title Dimethylguanidino Valerate: A Lifestyle‐Related Metabolite Associated With Future Coronary Artery Disease and Cardiovascular Mortality
title_full Dimethylguanidino Valerate: A Lifestyle‐Related Metabolite Associated With Future Coronary Artery Disease and Cardiovascular Mortality
title_fullStr Dimethylguanidino Valerate: A Lifestyle‐Related Metabolite Associated With Future Coronary Artery Disease and Cardiovascular Mortality
title_full_unstemmed Dimethylguanidino Valerate: A Lifestyle‐Related Metabolite Associated With Future Coronary Artery Disease and Cardiovascular Mortality
title_short Dimethylguanidino Valerate: A Lifestyle‐Related Metabolite Associated With Future Coronary Artery Disease and Cardiovascular Mortality
title_sort dimethylguanidino valerate: a lifestyle‐related metabolite associated with future coronary artery disease and cardiovascular mortality
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6806048/
https://www.ncbi.nlm.nih.gov/pubmed/31533499
http://dx.doi.org/10.1161/JAHA.119.012846
work_keys_str_mv AT ottossonfilip dimethylguanidinovaleratealifestylerelatedmetaboliteassociatedwithfuturecoronaryarterydiseaseandcardiovascularmortality
AT ericsonulrika dimethylguanidinovaleratealifestylerelatedmetaboliteassociatedwithfuturecoronaryarterydiseaseandcardiovascularmortality
AT almgrenpeter dimethylguanidinovaleratealifestylerelatedmetaboliteassociatedwithfuturecoronaryarterydiseaseandcardiovascularmortality
AT smitheinar dimethylguanidinovaleratealifestylerelatedmetaboliteassociatedwithfuturecoronaryarterydiseaseandcardiovascularmortality
AT brunkwalllouise dimethylguanidinovaleratealifestylerelatedmetaboliteassociatedwithfuturecoronaryarterydiseaseandcardiovascularmortality
AT hellstrandsophie dimethylguanidinovaleratealifestylerelatedmetaboliteassociatedwithfuturecoronaryarterydiseaseandcardiovascularmortality
AT nilssonpeterm dimethylguanidinovaleratealifestylerelatedmetaboliteassociatedwithfuturecoronaryarterydiseaseandcardiovascularmortality
AT orhomelandermarju dimethylguanidinovaleratealifestylerelatedmetaboliteassociatedwithfuturecoronaryarterydiseaseandcardiovascularmortality
AT fernandezceline dimethylguanidinovaleratealifestylerelatedmetaboliteassociatedwithfuturecoronaryarterydiseaseandcardiovascularmortality
AT melanderolle dimethylguanidinovaleratealifestylerelatedmetaboliteassociatedwithfuturecoronaryarterydiseaseandcardiovascularmortality